UC College of Medicine Offers a Taste of Medical School to Public
Students and lifelong learners of all ages are invited to get a sample of medical school by attending the 2005 Mini Medical College, a four-week course conducted by University of Cincinnati College of Medicine faculty.
The course will explore new trends in modern medicine and disease prevention and how they affect personal health. No medical or scientific background is needed to attend. The cost is $69 and includes eight lectures, an education notebook, a T-shirt and certificate of participation.
All classes are held in the
s Rieveschl Auditorium on Tuesdays from 6:30 to 8:30 p.m. To register, call (513) 556-6932 or visit
.
The schedule is as follows:
Oct. 11
Forensic PsychiatryCriminal Intent
Presented by John Kennedy, MD, assistant professor of clinical psychiatry, director of the COM Institute for Psychiatry and Law
A to Z: Drugs of Abuse
Presented by Jack Lipton, PhD, professor of psychiatry, director of the Division of Developmental Neuroscience
Oct. 18
Sure Everyone Should Have Medical Coverage, But
Presented by Bob Graham, MD, professor and holder of the Robert and Myfanwy Smith chair in the Department of Family Medicine
Monitoring the Brain: Who Will Wake Up?
Presented by Lori Shutter, MD, professor of neurology and neurosurgery and medical director of the Neuroscience Intensive Care Unit,
Oct. 25
Plastic SurgeryExtreme Makeover Edition
Presented by Anureet Bajaj, MD, assistant professor of surgery
Are the Eyes Really the Window of the Soul?
Presented by Robert Osher, MD, professor of ophthalmology
Nov. 1
HPV: A Link to Cervical Cancer
Presented by Paula Hillard, MD, professor in the Department of Obstetrics and Gynecology and the Department of Pediatrics
Parkinsons Disease: An Overview
Presented by Fredy Revilla, MD, assistant professor and head of the Department of Neurologys Division of Movement Disorders
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.